Last reviewed · How we verify

NCT06976749

Three-Dimensional Evaluation of Pharyngeal Airway and Facial Dimension Changes in Skeletal Class II Patients Treated With Twin Block Versus Myobrace Appliances

ENROLLING BY INVITATION NA Last updated 16 May 2025
What this trial tests

NA trial testing myobrace appliance in Class II Division 1 Adolescent Patients in 50 participants. Enrolling by invitation.

Timeline
20 May 2025
Primary endpoint
1 June 2026
1 August 2026

Quick facts

Lead sponsorUniversity of Baghdad
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment50
Start date20 May 2025
Primary completion1 June 2026
Estimated completion1 August 2026
Sites1 location across Iraq

Drugs / interventions tested

Conditions studied

Sponsor

University of Baghdad

Who can join

Adults 10 to 14, any sex, with Class II Division 1 Adolescent Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is intended primarily to compare the effects of two Class II correction appliances, namely Twin block and Myobrace appliances, on pharyngeal airway dimensions during the treatment of class II division 1 adolescent patients, also evaluates three dimensional (3D) changes of pharyngeal airway including: minimum cross-sectional area and volume using Cone Beam Computed Tomography (CBCT), skeletal, dentoalveolar, and soft tissue changes using cephalometric analysis, and three dimensional (3D) soft tissue changes using facial scans. The hypothesis being a consideration of no significant difference in the changes of pharyngeal airway and facial dimensions in skeletal class II patients before and after treatment with Twin block and Myobrace.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Baghdad trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06976749.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing